Autoimmune diseases will occur when the immune response inflicts damage to tissues in the body.
Attempts to overcome this disease have a lot to do but they have not yielded satisfying results. In this study, the function
of CD4+CD25+ regulatory T cells was evaluated for therapeutic potential to prevent the development of autoreactive T
The isolation of CD4+CD25+ regulatory T cells was performed by using FACS vantage. It was conducted by
taking a spleen of 6-week-old C57BL/6 mice. Cells having high purity (2x106) were intravenously injected into 3-weekold
CD122-/- mice. In this experiment we used congeneic mice as donors and transferred hosts. The result of adoptive
transfer was examined after 7 weeks.
Here we showed that the transfer of CD4+CD25+ regulatory T cells into CD122-/- mice significantly prevented the
development of abnormal T cells. The injection of CD4+CD25+ regulatory T cells derived from normal young mice into
CD122-/- mice could prevent the development of activated memory T cells and these cells were essential for maintaining
normal homeostasis (P >0.01).
In this study we obtained evidence that regulatory T cells (2x106) derived from normal young mice could
overcome diseases when transferred to the mouse models of autoimmune disorder.